<DOC>
	<DOCNO>NCT01380431</DOCNO>
	<brief_summary>The purpose study compare bioavailability Par Lisinopril 40 mg Tablets IPR Pharmaceuticals , Inc. Zestril ( R ) .</brief_summary>
	<brief_title>A Comparative Bioavailability Study Lisinopril Tablets , 40 mg - Effect Food Study</brief_title>
	<detailed_description>To compare bioavailability Par Lisinopril 40 mg Tablets IPR Pharmaceuticals , Inc. Zestril ( R ) , 40 mg - Effect Food Study</detailed_description>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>Males , healthy , 1850 year age , No plus minus 15 % ideal weight subject 's height define Metropolitan Life Insurance Company Statistical Bulletin 1983 , Without history asthma , angioedema , hypertension , psychiatric illness , organsystem ( cardiovascular , neurological , hematopoietic , renal , pulmonary , endocrine , gastrointestinal , ) disorder , ongoing infectious disease , alcohol drug abuse determine medical history and/or physical examination within 30 day prior start study . Deviations may acceptable deem clinically significant investigator . Blood chemistry ( include alkaline phosphatase , glucose , ALt , AST , LDH , BUN , GGT , creatinine , bilirubin , electrolytes ) , hematology ( include hemoglobin , hematocrit , red blood cell count , white blood cell count , differential , platelet count ) , urinalysis value within clinically acceptable limit upon evaluation investigator . The test perform within 30 day prior start study . No prescription drug within 14 day , OTC preparation ( exception acetaminophen , vitamin , medicate lozenge , dietary supplement topical medication ) within 7 day first drug administration , period . Deviations may acceptable evaluated investigator determine clinically significant . No alcohol consumption least 48 hour prior drug administration last blood collection , period . No known allergy lisinopril ACE ( angiotensin convert enzyme ) inhibitor , captopril enalapril , atropine . Acceptable electrocardiogram : sinus rhythm evidence AV block ischemic change . At screen checkin period , subject must blood pressure pulse rate within follow range : Systolic blood pressure ( 110150 mmHg ) ; Diastolic blood pressure ( 7095 mmHg ) ; Pulse ( 50105 bpm ) . Minor deviation ( 13 mmHg ) checkin may acceptable discretion physician investigator . For except first period checkin , subject 's vital sign measurement fall outside range specify , subject may , discretion physician investigator , allow remain enrol 0hour measurement make . If 0hour protocol vital sign requirement meet , investigator may allow dose subject 's continuation study . If 0hour vital sign requirement meet , subject dose must withdraw study . The blood pressure pulse measure subject seat least three minute . Subjects blood pressure pulse measurement outside range vital sign measurement repeat accord Standard Operating Procedure . No caffeine least 48 hour prior dose last blood collection , period . Negative HIV 1 , hepatitis B surface antigen urine screen drug abuse within 30 day prior start study . All Females , males young 18 year age old 50 year age eligible participate study . A weight plus minus 15 % ideal weight subject 's height define Metropolitan Life Insurance Company Statistical Bulletin 1983 . A medical history asthma , angioedema hypertension , psychiatric illness , organsystem ( cardiovascular , neurological , hepatic , hematopoietic , renal , pulmonary , endocrine , gastrointestinal ) disorder , ongoing infectious disease , alcohol drug abuse within 30 day prior start study . Blood chemistry ( include alkaline phosphatase , glucose , ALt , AST , LDH , BUN , GGT , creatinine , bilirubin , electrolytes ) , hematology ( include hemoglobin , hematocrit , red blood cell count , white blood cell count , differential , platelet count ) , urinalysis value within clinically acceptable limit upon evaluation investigator . The test perform within 30 day prior start study . Evidence usage prescription drug within 14 day , OTC preparation ( exception acetaminophen , vitamin , medicate lozenge , dietary supplement topical medication ) within 7 day first drug administration , period . Alcohol consumption within 48 hour prior drug administration . Known allergy lisinopril ACE ( angiotensin convert enzyme ) inhibitor , captopril enalapril , atropine . Unacceptable electrocardiogram : sinus rhythm evidence AV block ischemic change . Blood pressure pulse rate outside follow range : Systolic blood pressure ( 110150 mmHg ) ; Diastolic blood pressure ( 7095 mmHg ) ; Pulse ( 50105 bpm ) . Evidence caffeine use within last 48 hour , prior dose , study last blood collection , period . A positive HIV 1 , hepatitis B surface antigen urine screen drug abuse within 30 day prior start study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>bioequivalence , lisinopril , fed</keyword>
</DOC>